Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,100 | 9,935 | 26,428 | 37,219 | 58,755 |
| Receivables | 706 | 1,215 | 890 | 716 | N/A |
| TOTAL | $8,134 | $11,580 | $29,091 | $40,178 | $59,323 |
| Non-Current Assets | |||||
| PPE Net | 93 | 153 | 271 | 342 | 453 |
| Intangibles | 0 | 0 | 0 | 0 | 19,092 |
| Other Non-Current Assets | 1,485 | 1,723 | 1,897 | 320 | 524 |
| TOTAL | $1,578 | $1,876 | $2,168 | $662 | $20,069 |
| Total Assets | $9,712 | $13,456 | $31,259 | $40,840 | $79,392 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,876 | 2,127 | 3,022 | 976 | 1,297 |
| Other current liabilities | N/A | N/A | N/A | N/A | 12 |
| TOTAL | $2,210 | $2,428 | $3,262 | $1,216 | $1,545 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,171 | 1,505 | 1,613 | 57 | 291 |
| TOTAL | $1,171 | $1,505 | $1,613 | $57 | $298 |
| Total Liabilities | $3,381 | $3,933 | $4,875 | $1,273 | $1,843 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,786 | 10,174 | 10,174 | 8,143 | 8,119 |
| Common Shares | 13 | 10 | 10 | 8 | 8 |
| Retained earnings | -342,249 | -333,418 | -315,914 | -297,930 | -259,093 |
| TOTAL | $6,331 | $9,523 | $26,384 | $39,567 | $77,549 |
| Total Liabilities And Equity | $9,712 | $13,456 | $31,259 | $40,840 | $79,392 |